Getinge AB (GETI-B.ST), a medtech company, on Tuesday reported a profit before tax of SEK 789 million for the third quarter, a sharp increase from SEK 32 million in the same period a year earlier, mainly reflecting the absence of certain one-off items.
In the prior-year quarter, the company had recognized provisions related to investigations concerning the CGU in Brazil—SEK 289 million for Acute Care Therapies and SEK 193 million for Surgical Workflows.
Excluding one-time items, adjusted profit before tax rose to SEK 916 million from SEK 751 million in the prior year.
Operating profit declined to SEK 952 million from SEK 184 million last year.
Net profit surged to SEK 576 million or SEK 2.08 per share from SEK 8 million or SEK 0.01 per share a year ago.
Adjusted profit was SEK 668 million or SEK 2.42 per share, up from SEK 618 million or SEK 2.24 per share a year earlier.
Sales for the quarter grew to SEK 8.226 billion from SEK 7.87 billion for the previous year.
For the full year, the company has reaffirmed its sales growth outlook of 2%-5% organically.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.